OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Enrique Grande: New Review Highlights Major Advances in Perioperative Treatment for Bladder Cancer

Neoadjuvant vs Definitive ChemoRT in cN3M0 Esophageal Cancer: A Nationwide Dutch Study

Pelé’s Cause of Death: Brazilian Football King’s Battle With Colon Cancer

CT, MRI, and PET/CT in Cancer Diagnosis: Key Differences

City of Hope Receives $11 Million Gift to Advance Personalized Cancer Care

Oncology News, Insights, Stories by OncoDaily

LUNAR
Genitourinary Oncology

LUNAR Trial Update: ¹⁷⁷Lu-PNT2002 Before SBRT in Oligorecurrent Prostate Cancer

Beyond MSI Status: A New Biomarker of Immunotherapy Resistance in Colorectal Cancer
Immune Oncology

Beyond MSI Status: A New Biomarker of Immunotherapy Resistance in Colorectal Cancer

Zainab Shinkafi-Bagudu
Voices

Zainab Shinkafi-Bagudu Outlines Priorities for the Future of Global Cancer Control - UICC

Ryan Schoenfeld: A Call for Tech Leaders to Support the Future of Cancer Research

Filipe Coutinho: New Review Explores How Biological Ageing Shapes Cancer Treatment and Outcomes

Georgina Long: INTerpath-001 mRNA Vaccine Improves Recurrence-Free Survival in High-Risk Melanoma

Daiichi Sankyo Seeks Japan Approval for Trastuzumab Deruxtecan in HER2-Expressing Uterine Carcinosarcoma

Beyond Checkpoint Inhibitors: The Rise of T-Cell Engagers in Prostate Cancer

Kate Middleton Opens Up About Cancer Recovery: Why Healing Is Not Always Linear

Mohammad Al Nahedh Takes On Role of Oncology Medical Head at Novartis

Voices
Aakash Desai

Aakash Desai: Who Tests Pharmaceutical Ads in AI Chatbots?

Nelson Dusetti: Opportunity to Join a Seminar on How a Perturbed Microenvironment Regulates Tumour Cell Function and Therapy Response

Thaís Santana: Is ARPI Intensification in High-Risk Localized Prostate Cancer a Class Effect?

Cinzia Brunelli Presents Five Talks on the EUonQoL Project at the European Public Health Conference 2026

Christos Tsagkaris: Discussing How Ethical Dilemmas in Public Health Shape Communication with Patients and the Public

Cathy Eng: Opportunity to Join the Young Adult Cancer Symposium Hosted by Vanderbilt-Ingram Cancer Center

Jasmine Kamboj: How Can Mentorship Encourage Young Minds to Pursue Oncology?

FDA Approvals
Durvalumab

FDA Approves Durvalumab Plus Enfortumab Vedotin for Muscle-Invasive Bladder Cancer

FDA Approves Pimicotinib for TGCT Following Positive Phase 3 MANEUVER Trial Results

After a Decade Without a New Option, FDA Approves Amivantamab for Head and Neck Cancer

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

Excellence in Oncology Care (EIOC 2026)

INDEX Conferences & Exhibitions

13 Nov
Excellence in Oncology Care

ISCO 2026 Fall Clinical Meeting

Idaho Society of Clinical Oncology (ISCO)

13 Nov
ISCO 2026

The ESMO Advanced Course on Cholangiocarcinoma 2026

European Society For Medical Oncology (ESMO)

13 Nov
Advanced Course on Cholangiocarcinoma

Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2026

Mayo Clinic

13 Nov
Hepato-Pancreatico-Biliary Cancer

The PSOH Annual Meeting 2026

Pennsylvania Society of Oncology & Hematology (PSOH)

14 Nov
PSOH Annual Meeting

Rare Cancers Conference 2026: Advances in Diagnosis, Genomics, and Targeted Therapies

Binaytara

14 Nov
Rare Cancers Conference

The HSCO 2026 Annual Conference

Hawaii Society of Clinical Oncology

14 Nov
HSCO 2026

ESMO AI and Digital Oncology Congress 2026

European Society For Medical Oncology (ESMO)

16 Nov
ESMO

NCI Data Jamboree: Enhancing Data Sharing and Utility to Advance Cancer Research

National Cancer Institute

16 Nov
NCI Data Jamboree

ESTRO Advanced Imaging in Radiotherapy: Current Use, Future Developments, and the Integration of AI

European Society for Radiotherapy and Oncology (ESTRO)

16 Nov
Radiotherapy

Career Masterclass for Early Career Cancer Researchers

European Association for Cancer Research

17 Nov
Early Career Cancer Researchers

Immune-oncology
Beyond MSI Status: A New Biomarker of Immunotherapy Resistance in Colorectal Cancer

Beyond MSI Status: A New Biomarker of Immunotherapy Resistance in Colorectal Cancer

Antibiotics and Immunotherapy: What a 97,850-Patient Meta-Analysis Reveals

Beyond Checkpoint Inhibitors: The Rise of T-Cell Engagers in Prostate Cancer

Rituximab and Checkpoint Inhibitors: A New Strategy to Prevent Immune-Related Toxicity

PD-L1: One Biomarker, Three Different Scores

NEO-CESQ Trial: Can Molecular Biomarkers Predict Recurrence After Immunotherapy?

Professor Gianluca Franceschini on Surgical De-escalation: Rethinking Breast Surgery in the Immunotherapy Era

Gastrointestinal-Oncology
esophageal cancer

Neoadjuvant vs Definitive ChemoRT in cN3M0 Esophageal Cancer: A Nationwide Dutch Study

Tumor Budding in Colorectal Cancer: Grading and Prognosis

CEA Levels in Colorectal Cancer: Monitoring and Recurrence

Adagene Completes Phase 2 Enrollment for Muzastotug Plus Pembrolizumab in MSS Colorectal Cancer

10 Must-Read Posts in GI Oncology This Week

UNICORN Phase 2: Neoadjuvant Botensilimab Plus Balstilimab Shows Promising Activity in pMMR and dMMR Colon Cancer

Agenus Reports 51% 18-Month Survival With BOT+BAL in MSS Colorectal Cancer

Breast-Oncology
Breast Cancer

Beyond Cancer Survival: New Study Links Chemotherapy to Accelerated Biological Aging in Breast Cancer

A Second Chance at Breast Conservation: Reirradiation Challenges Mastectomy After Local Recurrence

Breast Cancer in Michelangelo’s Sistine Chapel? A 500-Year-Old Fresco Sparks a Modern Medical Debate

Premenopausal Breast Cancer: New Review Challenges One-Size-Fits-All Adjuvant Treatment Strategies

Pembrolizumab Achieves 70.8% Pathological Complete Response in Early TNBC: French Real-World Study Examines Treatment Delivery and Safety

ESMO 2026 Reshapes Metastatic Breast Cancer Treatment: ADCs Move Into First Line as Biomarkers Guide New Strategies

DESTINY-Breast09 Redefines First-Line HER2-Positive Breast Cancer: Balancing Efficacy, Safety, and Treatment Selection

Lung-Oncology
Zipalertinib

Zipalertinib Plus Chemotherapy Moves Toward FDA Review After Six-Month PFS Benefit in EGFR Exon 20 Insertion-Mutated Lung Cancer

One Procedure, Two Goals: Lung Biopsy and Cryoablation Show Promising Results in Early-Stage NSCLC

Beyond TROP2 Expression: AI-Based Biomarker May Predict Datopotamab Deruxtecan Benefit in Lung Cancer

Beyond EGFR Mutations: New Study Reveals Why Some Lung Cancer Cells Survive Osimertinib

Split-Course Lung SBRT: Novel Inhale–Exhale Technique May Reduce Rib and Chest Wall Radiation Exposure

HERON-Lung01: Ruzaltatug Rezetecan Reduces Progression Risk in EGFR-Mutated NSCLC Following EGFR-TKI Therapy

SABR Versus Surgery in Early-Stage NSCLC: New JCO Study Supports Surgical Resection, With Important Questions for Older Patients

OncoDaily TV
Burnout

Oncology Beyond Guidelines: Burnout, Imposter Syndrome, Mentorship & Cancer Prevention with Imène Hadji

Holistic Healing

Cancer Survivorship, Holistic Healing and Patient Advocacy with Rohini Singh Sisodia

ONCOFFEE

ONCOFFEE: Cancer Care in Nepal, Global Oncology, and Bridging Resource Gaps with Vivek Ghosh

The CML Evolution

The CML Evolution: Mastering Modern Algorithms in Chronic Myeloid Leukemia

Lynda Chin

The Future is Near. Can We Finally Stop Cancer Resistance? Dr. Lynda Chin

AI

Can you trust AI with your CANCER? Shaalan Beg

Christian Ntizimira

Continue to be human: Christian Ntizimira

Stephanie Kauffman

She Left Hollywood To Fight Cancer: Stephanie Kauffman

pablo allard

Childhood Cancer Survivor Who Changed the Law: Pablo Allard’s Advocacy Journey

Cancer Care

Personalizing Colorectal Cancer Care with ctDNA? Dr. Robert Lentz

Priti Patnaik, Independent journalism

Independent journalism in global health: Priti Patnaik

Treatment Paradigms, Karine Tawagi

Evolving Treatment Paradigms in Muscle-Invasive Bladder Cancer

Not To Miss
Zipalertinib

Zipalertinib Plus Chemotherapy Moves Toward FDA Review After Six-Month PFS Benefit in EGFR Exon 20 Insertion-Mutated Lung Cancer

Belzutifan Plus Lenvatinib Moves Closer to EU Approval for Advanced Kidney Cancer

Africa Cancer Control Implementation Forum 2026: Turning Cancer Policies into Better Patient Care

New Prostate Cancer Screening Guidelines Recommend Regular PSA Testing

Daiichi Sankyo Seeks Japan Approval for Trastuzumab Deruxtecan in HER2-Expressing Uterine Carcinosarcoma

Faeth Therapeutics Reports Phase 2 Results for PIKTOR in Endometrial Cancer

Beyond First-Generation ICIs: Module 2 of OncoDaily Academy’s Six-Part Programme on Immune Checkpoint Inhibitors

OncoGrants
Larson Research Grant

IronMatt Matthew Larson Research Grant 2027

ALK-Positive Cancer

Conquer Cancer ALK-Positive Cancer Young Investigator Award 2027

McCaskill-Stevens Career Development

NCI Worta McCaskill-Stevens Career Development Award 2027

FERO

FERO Cancer Dr. Josep Baselga Grant 2027: €300,000

Stanford Cancer Institute

Stanford Cancer Institute Fellowship Awards 2027

Young Investigator Award

Children’s Tumor Foundation Young Investigator Award 2027

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
Vincenza Conteduca

Vincenza Conteduca

Oncologists Location Foggia, Italy
Mary Gospodarowicz

Mary Gospodarowicz

Oncologists Location Toronto, Canada
Navneet Singh

Navneet Singh

Oncologists Location Chandigarh, India
Karen Knudsen

Karen Knudsen

Oncologists Location San Francisco, USA
Charbel Matar

Charbel Matar

Oncologists Location Washington, USA
Anjaly Mohan

Anjaly Mohan

Oncologists Location Thiruvananthapuram, India
Zulfiquer Otty

Zulfiquer Otty

Oncologists Location Townsville, Australia
Chandler Park

Chandler Park

Oncologists Location Louisville, USA

Drugs Atlas
Mosunetuzumab (Lunsumio, Lunsumio Velo): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Mosunetuzumab-axgb (Lunsumio) Nov 13, 2026 1:26 am
Epcoritamab (Epkinly): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Epcoritamab-bysp (Epkinly) Nov 13, 2026 1:25 am
Blinatumomab (Blincyto): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Blinatumomab (Blincyto) Nov 12, 2026 5:42 am
Inotuzumab Ozogamicin (Besponsa): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Inotuzumab ozogamicin (Besponsa) Nov 12, 2026 5:40 am
Gemtuzumab Ozogamicin (Mylotarg): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Gemtuzumab ozogamicin (Mylotarg) Nov 12, 2026 5:37 am
Brentuximab Vedotin (Adcetris): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Brentuximab Vedotin (Adcetris) Nov 12, 2026 5:35 am
Alemtuzumab (Campath, Lemtrada): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Alemtuzumab (Campath, Lemtrada) Nov 10, 2026 4:31 pm
Elotuzumab (Empliciti): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Elotuzumab (Empliciti) Nov 10, 2026 4:26 pm
Isatuximab (Sarclisa, Sarclisa Escena): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Isatuximab-irfc (Sarclisa, Sarclisa Escena) Nov 8, 2026 1:29 am
Daratumumab (Darzalex, Darzalex Faspro): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Daratumumab (Darzalex, Darzalex Faspro) Nov 8, 2026 1:28 am

OncoDaily Magazine

New Paper Alert
Filipe Coutinho

Filipe Coutinho: New Review Explores How Biological Ageing Shapes Cancer Treatment and Outcomes

Stephanie Lim

Alexandra Thoms Presents Research on Young-Onset Colorectal Cancer at COSA 2026

Nicholas Huntington

Nicholas Huntington: NK Cell-Dendritic Cell Interactions, A New Strategy to Overcome Resistance to Immunotherapy

Çetin Ordu

Çetin Ordu: New Study Supports Genomic Testing in Early-Stage Breast Cancer

Melvin L.K. Chua

Melvin L.K. Chua: An Important Achievement for Nasopharyngeal Carcinoma Research and Clinical Practice

Luciano Costa

Luciano Costa: The “BALI” Strategy for Preventing Infections in Multiple Myeloma Patients

OncoDaily Medical Journal

GU Oncology

10.69690/ODMJ-001-1026-8269

Psychosocial burden and lifestyle impact in patients with renal cell carcinoma: a patient-reported outcomes analysis
Original Research

Pediatric Oncology

10.69690/ODMJ-001-1026-8309

Limited Prognostic Value of Baseline Curie Score in Children with High-Risk Neuroblastoma Treated with Contemporary Multi-modal Therapy: A Single-Center Retrospective Cohort Study
Original Research

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews